FCGR1A and nonpapillary renal cell carcinoma: In addition, the summarised and analysed bulk RNA sequencing data from The Cancer Genome Atlas (TCGA) Program of the Human Protein Atlas (https://www.proteinatlas.org/ENSG00000150337‐FCGR1A) showed that ccRCC patients with high CD64 (FCGR1A) expression levels had worse prognoses (Figure 4b).